FDA-authorized DEN240047
Allix5
Clairity, Inc.
Allix5 generates a five-year breast-cancer-risk prediction from bilateral screening mammograms for eligible patients without known breast cancer at presentation; it is not...
- Modality
- Mammography/DBT
- Anatomy
- Breast
- Decision
- 2025-05-30